THE USE OF Q-Tof FOR THE CHARACTERIZATION OF AN N-LINKED GLYCOSYLATION SITE IN NATIVE CAULIFLOWER XYLOGLUCAN ENDOTRANS GLYCOSYLASE
Applications | 2004 | WatersInstrumentation
LC/TOF, LC/HRMS, LC/MS, LC/MS/MS
IndustriesProteomics
ManufacturerWaters
Key wordscauliflower, hex, xet, flg, applicationnote, xyloglucan, idf, nrt, translational, nachex, post, glycosidase, mass, translationally, native, modification, sequence, glycosylation, endotransglycosylases, sagvvtafylssnnaehd, ymax, digested, protein, oligosaccharide, waters, doubly, ions, treated, charged, coverage, tryptically, asparagine, nhac, site, enabled, peptides, micromass, tryptic, caplc, nanoscale, tof, nac, hexose, analysis, deglycosylated, bpi, from, conserved, data, obtained
Similar PDF
Structural Analysis of an O-Glycopeptide Derived from Recombinant Erythropoiet in by SYNAPT High Definit ion Mass Spectrometry (HDMS)
2009|Waters|Applications
S t r u c t u r a l A n a lys i s o f a n O - G lyc o p e p t i d e D e r i v e d f…
Key words
glycosylation, glycosylationpep, pepglycans, glycanswave, wavefragmentation, fragmentationcollision, collisionhdms, hdmssynapt, synaptglycopeptide, glycopeptideglycan, glycanhexnac, hexnacsite, sitedrift, driftaligned, alignedions
Recombinant SARS-CoV-2 Receptor Binding Domain: Comprehensive Top-Down Sequence Confirmation, Curation and O-Glycosylation Site Determination
2021|Bruker|Applications
Recombinant SARS-CoV-2 Receptor Binding Domain: Comprehensive Top-Down Sequence Confirmation, Curation and O-Glycosylation Site Determination Know your SARS-CoV-2 antigen structure before it´s use in research and diagnostics Abstract The COVID pandemic dramatically influences our life and the demand remains very high…
Key words
maldi, maldiisd, isdrbd, rbdglycosylation, glycosylationbruker, brukerrbds, rbdsterminal, terminalsialexo, sialexosequence, sequencepngase, pngasedown, downspectra, spectracho, chocompass, compasstop
High Throughput Peptide Mapping with the Vanquish UHPLC System and the Q Exactive HF Mass Spectrometer
2015|Thermo Fisher Scientific|Posters
this study we have analyzed two commercially available drug products: rituximab (trade names MabThera and Rituxan®) and denosumab (trade names Prolia® and XGEVA®). FIGURE 1. General structure of mAbs and their biological and physico-chemical characteristics. Physicochemical Characteristics Biological Characteristics High…
Key words
chain, chainheavy, heavyrituximab, rituximabmodifications, modificationspeptide, peptidemodification, modificationgradient, gradientmapping, mappingdifferent, differentexactive, exactiveheterogeneity, heterogeneitysequence, sequencenames, nameslight, lightterminal
ApplicAtion SolutionS for BiophArmAceuticAlS A Focus on Protein Therapeutics Introduction: Key Challenges in Biopharmaceutical Characterization .............................................................................................5 7 PROTEIN mass aNalysIs comprehensive and routine characterization of proteins and peptides by lc/mS and lc/mS e ...............................................................9 characterization of an igG1 monoclonal Antibody…
Key words
uplc, uplcpeptide, peptideprotein, proteinwaters, watersacquity, acquityglycan, glycanantibody, antibodymass, massglycans, glycanspeptides, peptidessystem, systemmapping, mappinganalysis, analysisintact, intactmonoclonal